S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 20 of 20

Issue Date	Title / Author(s) / Citation	File
2006-12	Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells Lee, Ju-Hee; Park, Jung-Hyun; Jung, Yeonjoo; Kim, Jee-Hyun; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.5 No.12, pp.3085-3095	DOI
2010-06	Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer Lee, Kyeong-sook; Lee, You-soub; Lee, Jong-min; Ito, Kosei; Cinghu, Senthilkumar; Kim, Jang-hyun; Jang, Ju-won; Li, Yinghui; Goh, Yun-mi; Chi, Xin-zi; Wee, Heejun; Lee, Hang Woong; Hosoya, Akihiro; Chung, Jin-haeng; Jang, Ja-june; Kundu, Joydeb Kumar; Surh, Young Joon; Kim, Wun-jae; Ito, Yoshiaki; Jung, Han-sung; Bae, Sukchul Oncogene, Vol.29 No.23, pp.3349-3361	DOI
2011-07	RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma Catenacci, Daniel V. T.; Cervantes, Gustavo; Yala, Soheil; Nelson, Erik A.; El-Hashani, Essam; Kanteti, Rajani; El Dinali, Mohamed; Hasina, Rifat; Braegelmann, Johannes; Seiwert, Tanguy; Sanicola, Michele; Henderson, Les; Grushko, Tatyana A.; Olopade, Olufunmilayo; Karrison, Theodore; Bang, Yung-Jue; Kim, Woo Ho; Tretiakova, Maria; Vokes, Everett; Frank, David A.; Kindler, Hedy L.; Huet, Heather; Salgia, Ravi Cancer Biology and Therapy, Vol.12 No.1, pp.9-46	DOI
2011-12	MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib Lennerz, Jochen K.; Kwak, Eunice L.; Ackerman, Allison; Michael, Michael; Fox, Stephen B.; Bergethon, Kristin; Lauwers, Gregory Y.; Christensen, James G.; Wilner, Keith D.; Haber, Daniel A.; Salgia, Ravi; Bang, Yung-Jue; Clark, Jeffrey W.; Solomon, Benjamin J.; Iafrate, A. John Journal of Clinical Oncology, Vol.29 No.36, pp.4803-4810	DOI
2012-03	Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells Kim, Hye Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Anti-Cancer Drugs, Vol.23 No.3, pp.288-297	DOI
2016-07	Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer Suh, Koung Jin; Ryu, Han Suk; Lee, Kyung-Hun; Kim, Hyojin; Min, Ahrum; Kim, Tae-Yong; Yang, Yaewon; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.158 No.2, pp.233-241	DOI
2016-09	Therapeutic implication of HER2 in advanced biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Cha, Yongjun; Ha, Hyerim; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Oncotarget, Vol.7 No.36, pp.58007-58021	DOI
2017-01	L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma Jo, Dong Hyun; Lee, Kyungmin; Kim, Jin Hyoung; Jun, Hyoung Oh; Kim, Younghoon; Cho, Young-Lai; Yu, Young Suk; Min, Jeong-Ki; Kim, Jeong Hun Oncotarget, Vol.8 No.9, pp.15441-15452	DOI
2017-06	Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial Chu, Michael P.; Hecht, J. Randolph; Slamon, Dennis; Wainberg, Zev A.; Bang, Yung-Jue; Hoff, Paulo M.; Sobrero, Alberto; Qin, Shukui; Afenjar, Karen; Houe, Vincent; King, Karen; Koski, Sheryl; Mulder, Karen; Hiller, Julie Price; Scarfe, Andrew; Spratlin, Jennifer; Huang, Yingjie J.; Khan-Wasti, Saba; Chua, Neil; Sawyer, Michael B. JAMA oncology, Vol.3 No.6, pp.767-773	DOI
2017-06	Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition Jin, Mei Hua; Nam, Ah-Rong; Park, Ji Eun; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn Molecular Cancer Therapeutics, Vol.16 No.6, pp.1145-1154	DOI
2017-06	Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy Masuda, N.; Lee, S. -J.; Ohtani, S.; Im, Y. -H.; Lee, E. -S.; Yokota, I.; Kuroi, K.; Im, S. -A.; Park, B. -W.; Kim, S. -B.; Yanagita, Y.; Ohno, S.; Takao, S.; Aogi, K.; Iwata, H.; Jeong, J.; Kim, A.; Park, K. -H.; Sasano, H.; Ohashi, Y.; Toi, M. New England Journal of Medicine, Vol.376 No.22, pp.2147-2159	DOI
2017-08	A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer Michael, Michael; Bang, Yung-Jue; Park, Young Suk; Kang, Yoon-Koo; Kim, Tae Min; Hamid, Oday; Thornton, Donald; Tate, Sonya C.; Raddad, Eyas; Tie, Jeanne Targeted Oncology, Vol.12 No.4, pp.463-474	DOI
2018-01	S-1-induced lacrimal drainage obstruction and its association with ingredients/metabolites of S-1 in tears and plasma: A prospective multi-institutional study Kim, Namju; Kim, Jin Won; Baek, Je-Hyun; Kim, Jin-Soo; Choung, Ho-Kyung; Kim, Tae-Yong; Lee, Kyung-Hun; Bang, Yung-Jue; Khwarg, Sang In; Ahn, Sang-Hoon; Park, Do Joong; Kim, Hyung-Ho; Chung, Jae-Yong; Ahn, Soyeon; Lee, Keun-Wook Cancer Research and Treatment, Vol.50 No.1, pp.30-39	DOI
2019-06	Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea Im, Seock-Ah; Lee, Dae-Won; Kang, Ryungwoo; Kim, Jee Hyun; Kim, Dong-Wan; Jang, In-Jin; Lee, Jong-Seok; Bang, Yung-Jue Chinese Clinical Oncology, Vol.8 No.3, p. 27	view file DOI
2020-01	HER2-targeted therapies - a role beyond breast cancer Oh, Do-Youn; Bang, Yung-Jue Nature Reviews Clinical Oncology, Vol.17 No.1, pp.33-48	DOI
2020-07	Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma Catenacci, Daniel V. T.; Rasco, Drew; Lee, Jeeyun; Rha, Sun Young; Lee, Keun-Wook; Bang, Yung Jue; Bendell, Johanna; Enzinger, Peter; Marina, Neyssa; Xiang, Hong; Deng, Wei; Powers, Janine; Wainberg, Zev A. Journal of Clinical Oncology, Vol.38 No.21, pp.2418-2426	DOI
2020-10	Glomerular Hyperfiltration and Cancer: A Nationwide Population-Based Study Kim, Yaerim; Lee, Soojin; Lee, Yeonhee; Kang, Min Woo; Park, Sehoon; Park, Sanghyun; Han, Kyungdo; Paek, Jin Hyuk; Park, Woo Yeong; Jin, Kyubok; Han, Seungyeup; Han, Seung Seok; Lee, Hajeong; Lee, Jung Pyo; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Kim, Dong Ki Cancer Epidemiology Biomarkers and Prevention, Vol.29 No.10, pp.2070-2077	DOI
2021	DNA Damage Repair Inhibitor for Breast Cancer Treatment Min, Ahrum; Lee, Kyung-Hun; Im, Seock-Ah Advances in Experimental Medicine and Biology, Vol.1187, pp.159-179	DOI
2021-04	Efficacy of pembrolizumab monotherapy for advanced gastric/gastroesophageal junction cancer with programmed death ligand 1 combined positive score ≥10 Wainberg, Zev A.; Fuchs, Charles S.; Tabernero, Josep; Shitara, Kohei; Muro, Kei; Van Cutsem, Eric; Bang, Yung-Jue; Chung, Hyun Cheol; Yamaguchi, Kensei; Varga, Eniko; Chen, Jen-Shi; Hochhauser, Daniel; Thuss-Patience, Peter; Al-Batran, Salah-Eddin; Garrido, Marcelo; Kher, Uma; Shih, Chie-Schin; Shah, Sukrut; Bhagia, Pooja; Chao, Joseph Clinical Cancer Research, Vol.27 No.7, pp.1923-1931	DOI
2023-07	Associations between Physical Activity and Incidence of Cancer among Overweight Adults in Korea: Results from the Health Examinees-G Study Choi, Jaesung; Park, JooYong; Kim, Ji-Eun; Lee, Miyoung; Kang, Daehee; Shin, Aesun; Choi, Ji-Yeob Cancer Prevention Research, Vol.16 No.7, pp.405-418	DOI